Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010

Abstract Background The risk of multiple sclerosis (MS) increases with increasing latitude. Taking into consideration that Norway has a large latitude range, a south-to-north gradient would be expected. However, previous studies have reported an uneven distribution of the disease in Norway, with a r...

Full description

Bibliographic Details
Main Authors: Benjaminsen, Espen, Olavsen, Johnny, Karlberg, Merethe, Alstadhaug, Karl B
Format: Article in Journal/Newspaper
Language:English
Published: BioMed Central Ltd. 2014
Subjects:
Online Access:http://www.biomedcentral.com/1471-2377/14/226
id ftbiomed:oai:biomedcentral.com:s12883-014-0226-8
record_format openpolar
spelling ftbiomed:oai:biomedcentral.com:s12883-014-0226-8 2023-05-15T17:24:34+02:00 Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010 Benjaminsen, Espen Olavsen, Johnny Karlberg, Merethe Alstadhaug, Karl B 2014-12-04 http://www.biomedcentral.com/1471-2377/14/226 en eng BioMed Central Ltd. http://www.biomedcentral.com/1471-2377/14/226 Copyright 2014 Benjaminsen et al.; licensee BioMed Central Ltd. Multiple sclerosis Norway Epidemiology Prevalence Incidence Research article 2014 ftbiomed 2014-12-14T00:46:07Z Abstract Background The risk of multiple sclerosis (MS) increases with increasing latitude. Taking into consideration that Norway has a large latitude range, a south-to-north gradient would be expected. However, previous studies have reported an uneven distribution of the disease in Norway, with a relatively low prevalence in the most northern parts of the country. We describe the incidence and prevalence of MS in a county in the north of Norway over a period of 40 years. Methods All patients with MS living in Nordland County in the period 1970–2010 were identified by reviewing hospital charts. The patients were included if they met the criteria of definitive or probable MS according to Poser [Ann Neurol 13:227-231, 1983] or MS according to McDonalds [Ann Neurol 50:121-127, 2001]. Point prevalence at the beginning of the decades was calculated. The average annual incidence was calculated for 5-year periods. Results The total crude prevalence on January 1, 2010 was 182.4 per 100 000. The annual incidence continuously increased from 0.7 per 100 000 in 1970 – 1974 to 10.1 per 100,000 in 2005 – 2009. The time delay from the first symptom to diagnosis was stable from 1975 to 2010. The proportion of primary progressive MS in the prevalence numbers was 38.2% in 1980, and decreases continuously, to 18.6% in 2010. The female to male prevalence ratio has been stable since 1990 at 2.2 to 1. Conclusion The prevalence and the incidence of MS have steadily increased over a 40 year period. Nordland County is a high-risk area for MS. Article in Journal/Newspaper Nordland Nordland Nordland BioMed Central Norway
institution Open Polar
collection BioMed Central
op_collection_id ftbiomed
language English
topic Multiple sclerosis
Norway
Epidemiology
Prevalence
Incidence
spellingShingle Multiple sclerosis
Norway
Epidemiology
Prevalence
Incidence
Benjaminsen, Espen
Olavsen, Johnny
Karlberg, Merethe
Alstadhaug, Karl B
Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010
topic_facet Multiple sclerosis
Norway
Epidemiology
Prevalence
Incidence
description Abstract Background The risk of multiple sclerosis (MS) increases with increasing latitude. Taking into consideration that Norway has a large latitude range, a south-to-north gradient would be expected. However, previous studies have reported an uneven distribution of the disease in Norway, with a relatively low prevalence in the most northern parts of the country. We describe the incidence and prevalence of MS in a county in the north of Norway over a period of 40 years. Methods All patients with MS living in Nordland County in the period 1970–2010 were identified by reviewing hospital charts. The patients were included if they met the criteria of definitive or probable MS according to Poser [Ann Neurol 13:227-231, 1983] or MS according to McDonalds [Ann Neurol 50:121-127, 2001]. Point prevalence at the beginning of the decades was calculated. The average annual incidence was calculated for 5-year periods. Results The total crude prevalence on January 1, 2010 was 182.4 per 100 000. The annual incidence continuously increased from 0.7 per 100 000 in 1970 – 1974 to 10.1 per 100,000 in 2005 – 2009. The time delay from the first symptom to diagnosis was stable from 1975 to 2010. The proportion of primary progressive MS in the prevalence numbers was 38.2% in 1980, and decreases continuously, to 18.6% in 2010. The female to male prevalence ratio has been stable since 1990 at 2.2 to 1. Conclusion The prevalence and the incidence of MS have steadily increased over a 40 year period. Nordland County is a high-risk area for MS.
format Article in Journal/Newspaper
author Benjaminsen, Espen
Olavsen, Johnny
Karlberg, Merethe
Alstadhaug, Karl B
author_facet Benjaminsen, Espen
Olavsen, Johnny
Karlberg, Merethe
Alstadhaug, Karl B
author_sort Benjaminsen, Espen
title Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010
title_short Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010
title_full Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010
title_fullStr Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010
title_full_unstemmed Multiple sclerosis in the far north - incidence and prevalence in Nordland County, Norway, 1970–2010
title_sort multiple sclerosis in the far north - incidence and prevalence in nordland county, norway, 1970–2010
publisher BioMed Central Ltd.
publishDate 2014
url http://www.biomedcentral.com/1471-2377/14/226
geographic Norway
geographic_facet Norway
genre Nordland
Nordland
Nordland
genre_facet Nordland
Nordland
Nordland
op_relation http://www.biomedcentral.com/1471-2377/14/226
op_rights Copyright 2014 Benjaminsen et al.; licensee BioMed Central Ltd.
_version_ 1766115658744987648